BioXcel Therapeutics
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Long Wharf Dr Fl 12, New Haven, Conn...Phone Number
(475) 238-6837Website
www.bioxceltherapeutics.comRevenue
<$5 MillionStock Symbol
BTAIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. The companys wholly owned, clinical-stage subsidiary, OnkosXcel Therapeutics, is focused on developing medicines in immuno-oncology.Explore more
BioXcel Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioXcel Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if BioXcel Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if BioXcel Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on BioXcel Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioXcel Therapeutics
Product Launch: Get notified when BioXcel Therapeutics launches new products
Funding: Get notified immidiatlly once BioXcel Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
BioXcel Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioXcel Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to BioXcel Therapeutics
Compare insights from companies similar to BioXcel Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioXcel Therapeutics
<$5M
11-50
Public
$260M
2017
Richard SteinhartSenior Vice President & Chief Financial Officer
Company Profile Activity
Activity Insights
BioXcel Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioXcel Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioXcel Therapeutics.
BioXcel Therapeutics financials insights
Gather financial insights about BioXcel Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$260M
BioXcel Therapeutics Tech Stack
A closer look at the technologies used by BioXcel Therapeutics
See more technologies
Most Recent Scoops
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
BioXcel Therapeutics News & Media
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
FDA accepted sNDA for IGALMI® use in at-home (outpatient) setting; set Nov. 14, 2026, as PDUFA dateBioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
Live event to be held on Thursday, April 23, at 2:00 p.m. ETDid BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioXcel Therapeutics
Sign Up For FreeTo access detailed company insights
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. The companys wholly owned, clinical-stage subsidiary, OnkosXcel Therapeutics, is focused on developing medicines in immuno-oncology.... Read More
